What is Levita Magnetics?
Headquartered in Silicon Valley, Levita Magnetics has developed the first and only Magnetic Surgery® platform, the Levita Magnetic Surgical System. Founded by innovator and surgeon Dr. Alberto Rodriguez-Navarro, this proprietary technology is designed to evolve minimally invasive surgery by minimizing the surgical footprint and improving patient outcomes. The system is the first magnetic surgical platform to receive FDA clearance, marking a significant milestone in surgical innovation. The Levita Magnetic-Assisted Robotic Surgery (MARS) Platform is engineered to enhance the efficiency and quality of high-volume abdominal surgeries, offering surgeons improved access and a less invasive approach with fewer incisions, while maintaining full control of the platform and instruments.
How much funding has Levita Magnetics raised?
Levita Magnetics has raised a total of $56.7M across 1 funding round:
Series C
$26M
Series C (2022): $26M, investors not publicly disclosed
What's next for Levita Magnetics?
The recent major strategic investment, part of a significant enterprise-level funding initiative, positions Levita Magnetics for accelerated growth and market penetration. This capital infusion is expected to fuel further development of its groundbreaking Magnetic Surgery® platform, expand its commercial reach, and potentially drive broader adoption across various surgical specialties. The company's focus on improving patient outcomes and reducing surgical invasiveness aligns with key trends in modern healthcare, suggesting a strong trajectory for future expansion and potential for further strategic partnerships.
See full Levita Magnetics company page
